SS Innovations Wins Outstanding Company Award, SSi Mantra Logs 11,719 Procedures
SSII•SS Innovations International won the Outstanding Company award at the 2026 Surgical Robotics Industry Awards, outperforming nine established finalists. As of June 22, the SSi Mantra system recorded 11,719 multi-specialty procedures—including 612 cardiac, 175 telesurgeries and 212 pediatric cases—with 2,100 trained physicians and approval in 14 countries.
1. Award Recognition
SS Innovations International was named Outstanding Company at the 2026 Surgical Robotics Industry Awards, surpassing nine well-established finalists. The accolade highlights the company’s commercial success, novel robotic technology, positive societal impact and strong ethical and employment practices.
2. SSi Mantra Usage Statistics
By June 22, the SSi Mantra system had completed 11,719 multi-specialty procedures, including 612 cardiac operations, 175 telesurgeries and 212 pediatric surgeries. Over 2,100 physicians have been trained on the platform, which supports more than 170 different surgical procedures.
3. Global Approvals and Market Expansion
The SSi Mantra holds regulatory approval in 14 countries—including India, United Arab Emirates, Kenya, Colombia and Ukraine—positioning SS Innovations for further international growth. Its modular multi-arm design, 3D 4K imaging, ergonomic surgeon console and portable telesurgery option cater to diverse global surgical needs.
